Search research articles
Contact Us
Filters
Showing results (61-70 of 105) with videos related to
Page
of 11
Sort By:
Nature
|
May 2, 1985
Co-localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy
B Wolfson, R W Manning, L G Davis, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
June 6, 2000
Detection of dopaminergic modulators in a tier I screening battery for identifying endocrine-active compounds (EACs)
J C O'Connor, L G Davis, S R Frame, et al.
Biological Psychiatry
|
January 1, 1981
Lecithin administration in tardive dyskinesia: clinical and biomedical correlates
I V Jackson, L G Davis, R K Cohen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 25, 1999
Detection of the environmental antiandrogen p,p-DDE in CD and long-evans rats using a tier I screening battery and a Hershberger assay
J C O'Connor, S R Frame, L G Davis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 25, 1999
Detection of thyroid toxicants in a tier I screening battery and alterations in thyroid endpoints over 28 days of exposure
J C O'Connor, S R Frame, L G Davis, et al.
Health Education Quarterly
|
January 1, 1988
Do only the healthy intend to participate in worksite health promotion?
K J Zavela, L G Davis, R R Cottrell, et al.
FEBS Letters
|
May 15, 1976
31P nuclear magnetic resonance studies on the phosphoglycopeptides obtained from rat brain glycoprotein
L G Davis, A J Costello, J I Javaid, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 1, 1997
Development of a Tier I screening battery for detecting endocrine-active compounds (EACs)
J C Cook, M A Kaplan, L G Davis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
April 25, 2000
Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486
J C O'Connor, L G Davis, S R Frame, et al.
The Journal of Infectious Diseases
|
October 1, 1991
A double-blind, placebo-controlled cytogenetic study of oral acyclovir in patients with recurrent genital herpes
D Clive, L Corey, R C Reichman, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 105) with videos related to
Sort By:
Page
of 11
Nature
|
May 2, 1985
Co-localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy
B Wolfson, R W Manning, L G Davis, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
June 6, 2000
Detection of dopaminergic modulators in a tier I screening battery for identifying endocrine-active compounds (EACs)
J C O'Connor, L G Davis, S R Frame, et al.
Biological Psychiatry
|
January 1, 1981
Lecithin administration in tardive dyskinesia: clinical and biomedical correlates
I V Jackson, L G Davis, R K Cohen, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 25, 1999
Detection of the environmental antiandrogen p,p-DDE in CD and long-evans rats using a tier I screening battery and a Hershberger assay
J C O'Connor, S R Frame, L G Davis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
September 25, 1999
Detection of thyroid toxicants in a tier I screening battery and alterations in thyroid endpoints over 28 days of exposure
J C O'Connor, S R Frame, L G Davis, et al.
Health Education Quarterly
|
January 1, 1988
Do only the healthy intend to participate in worksite health promotion?
K J Zavela, L G Davis, R R Cottrell, et al.
FEBS Letters
|
May 15, 1976
31P nuclear magnetic resonance studies on the phosphoglycopeptides obtained from rat brain glycoprotein
L G Davis, A J Costello, J I Javaid, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 1, 1997
Development of a Tier I screening battery for detecting endocrine-active compounds (EACs)
J C Cook, M A Kaplan, L G Davis, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
April 25, 2000
Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486
J C O'Connor, L G Davis, S R Frame, et al.
The Journal of Infectious Diseases
|
October 1, 1991
A double-blind, placebo-controlled cytogenetic study of oral acyclovir in patients with recurrent genital herpes
D Clive, L Corey, R C Reichman, et al.
Page
of 11